BJØRGVIN THERAPEUTICS GROUP AS
Signals
- Negativ egenkapital 2025 Bokført egenkapital er negativ (−47k kr).
BJØRGVIN THERAPEUTICS GROUP AS is registered as a limited company in Bergen, Vestland with organisation number 933253503. The business is classified under manufacture of pharmaceutical preparations (NACE 21.200). The company was incorporated in 2024. Registered share capital is NOK 50,000, divided into 50000 shares. The company's stated purpose is: “Produksjon av legemidler.”. The most recent filed accounts, for the 2025 financial year, show NOK 0 in revenue and NOK −84,000 in operating profit.
Key figures · 2025
Financial health · 2025
Solidity capped at Weak because equity is below NOK 100,000.
Who owns BJØRGVIN THERAPEUTICS GROUP AS?
BJØRGVIN THERAPEUTICS GROUP AS has 12 registered shareholders:
- Jarle Sidney Diesen 14.5%
- EMINELL INVEST AS 14.5%
- TRES BIOTECHNOLOGY AS 14.5%
- Per Øyvind Enger 14.5%
- GRIFFENFELDT AS 8.0%
- Marcel Sandberg 8.0%
- Gro Gausdal 8.0%
- Nicolas Mattias Del Rio Fuenzalida 4.0%
- Aleksander Dahle Gandrudbakken 4.0%
- LUNDEVALL HOLDING AS 4.0%
- Calum Leitch 4.0%
- Francesco Angelucci 2.0%
Frequently asked questions about BJØRGVIN THERAPEUTICS GROUP AS
Who owns BJØRGVIN THERAPEUTICS GROUP AS?
Jarle Sidney Diesen is the largest registered owner, with 14.5%.
What is the revenue of BJØRGVIN THERAPEUTICS GROUP AS?
BJØRGVIN THERAPEUTICS GROUP AS had revenue of NOK 0 in 2025.
Who is the general manager of BJØRGVIN THERAPEUTICS GROUP AS?
Gro Gausdal is registered as general manager of BJØRGVIN THERAPEUTICS GROUP AS.
Where is BJØRGVIN THERAPEUTICS GROUP AS based?
BJØRGVIN THERAPEUTICS GROUP AS has its business address in Loddefjord.
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 03.10.2026.